Rumin8 has developed a pharmaceutical approach to stabilize and manufacture Tribromomethane (TBM) for the reduction of methane emissions from livestock. Our proprietary technology uses a scalable and cost effective process to stabilize the synthetic active compound originally identified in seaweed and produce GMP-compliant formulations. In trials, our feed additive significantly reduces methane production and improves productivity in cattle. Rumin8 is also optimizing multiple formulations and delivery modalities to suit the diverse beef and dairy production systems worldwide. 

Industries

Agriculture
Biotechnology
Environment
Environmental
Medical Pharmaceuticals
Pharmaceuticals

Office Locations

Perth, Australia (Global HQ) & Wayne, PA (US HQ)